Levothyroxine Sodium Tablets Recalled for Potential Labeling Error
Aidapak Services, LLC is recalling Levothyroxine Sodium tablets that may have been mislabeled as Multivitamin/Multimineral tablets.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported injuries or illnesses, fitting the criteria for a moderate severity score.
Plain-English summary
Aidapak Services, LLC is recalling Levothyroxine Sodium, Tablet, 112 mcg, NDC 00074929690, due to a potential labeling error. The recall is classified as Class II by the U.S. Food and Drug Administration.
The recalled product may have been mislabeled as Multivitamin/Multimineral, Tablet, 0 mg, NDC 00536406001. The specific pedigree for the recalled Levothyroxine Sodium is AD22865_16 with an expiration date of 5/2/2014. The potentially mislabeled product has pedigree AD22865_13 and the same expiration date.
Repacked drugs were distributed in Arizona, California, Oregon, and Washington. Consumers should check their medication labels and contact their healthcare provider or pharmacist if they have the affected product.
The recalled product
- Product
- LEVOTHYROXINE SODIUM, Tablet, 112 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074929690.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 90
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- LEVOTHYROXINE SODIUM
- Tablet
- 112 mcg has the following codes: Pedigree: AD22865_16
- EXP: 5/2/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateLiothyronine Sodium Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateFDA Recalls Potentially Mislabeled Levothyroxine/Liothyronine Tablets
FDA (Drugs) · 2014-01-22
- ModerateMultivitamin Chew Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Multivitamin Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- HighLiothyronine Sodium Tablets Recalled for Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Tramadol Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22